Apollo Health Ventures is an early-stage venture capital firm that focuses on co-founding and investing in transformative healthcare companies targeting age-related diseases and the biology of aging. The firm employs a strategy of both active venture creation through its "Venture Lab" and investing in best-in-class companies within the biotechnology, data platforms, therapeutics, and health-tech sectors.
100% of their portfolio is in Biotech & Life Sciences. Their most common stage is seed (50% of deals). Average disclosed round size is $31.2M (across 4 rounds with reported amounts).
Portfolio
4
Fund Size
$180M
Top Stage
Seed
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
4 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| SScripta Therapeutics | Seed | $12M | Nov 2025 |
 Booster Therapeutics | Seed | $15M | Oct 2024 |
 Aeovian Pharmaceuticals | Unknown | $50M | Mar 2024 |
 Auron Therapeutics | Series A | $48M | Jul 2022 |
Top Co-Investors
Novo Holdings1 shared
Sofinnova Partners1 shared
venBio1 shared
Btov1 shared
Oxford Science Enterprises1 shared
AlbionVC1 shared
YZR Capital1 shared
DCVC1 shared
Mubadala Ventures1 shared
Polaris Venture Partners1 shared
Arkin Bio Ventures1 shared
Qiming Venture Partners USA1 shared
Eli Lilly and Company1 shared
BrightEdge1 shared
Casdin Capital1 shared
Last updated: 28 April 2026